AdvertisementAdvisers to the FDA back first over-the-counter birth control pillUpdated May 10, 2023Scott HensleyRob SteinfacebookEmailAn advisory panel to the Food and Drug Administration supported drugmaker Perrigo's application to sell the oral contraceptive Opill without a prescription. (Perrigo)This article was originally published on May 10, 2023.
